Search

You searched for "infection"

3337 results found

Young ESPO - calling all young paediatric otolaryngologists

5 October 2020
Young ESPO welcomes all junior otolaryngologists with a special interest in paediatrics to become part of a community of training doctors, and share clinical and research knowledge on paediatric ENT!

OBITUARY: Peter Rhys Evans (1948–2022)

7 October 2022
On 3 June 2022, we lost a widely recognised and respected ENT/head and neck surgeon, Mr Peter Rhys Evans.

EUHA 2024: 68th International Congress of Hearing Aid Acousticians

16 October 2024 -18 October 2024 | ENTA - Audiology - Adult, ENTA - Audiology - Diagnostic, ENTA - Audiology - Paediatric, ENTA - Auditory Implants, ENTA - Vestibular Disorders, ENTA - Tinnitus
A big stage for hearing aid acousticians Tom Aerts, Herentals, Belgium From 16 to 18 October 2024 in Hanover, the EUHA recorded around 8700 participants at the hearing aid acousticians congress and industry exhibition. The world's largest industry event impressed...

ManCAD Research CAPers Conference

16 September 2024 -17 September 2024 | ENTA - Audiology - Adult, ENTA - Audiology - Diagnostic, ENTA - Audiology - Paediatric
ManCAD's upcoming inaugural research conference has been playfully named ‘Research CAPers’ – as in Research Clinical Auditory Papers. This year’s conference highlighted the scientific accomplishments of Professor Dave Moore – who is retiring later this year from his various academic roles.

Audiology and speech language pathology programmes in India: an overview of education and career opportunities

1 January 2018 | | ENTA - Audiology - Diagnostic, ENTA - ENT
This article is provided by Lalsa Shilpa Perepa, a Clinical Audiologist who started her audiology career in India. Audiology and speech language pathology (ASLP) courses in India are offered by various colleges and institutes that are affiliated with different universities...

Are we making progress on tinnitus?

23 May 2017 | | ENTA - Audiology - Diagnostic, ENTA - Otology
One of the aspects of tinnitus that drew me into it becoming a major theme of my clinical and research work was how little work had been done when I began to see patients in the mid 1980s. This struck...

Deaf identity is not cookie cutter shaped: a CI user in a hearing world

25 August 2023 | | ENTA - Audiology - Adult, ENTA - Auditory Implants
Sam Burgess tells us what deaf identity means to her as a service manager in a busy healthcare library, with a cochlear Implant. To begin with, I have been deaf since birth due to congenital rubella. I have not known...

In conversation with Ricard Simo

1 March 2015 | | ENTA - ENT
Ricard Simo is a Consultant Head and Neck Surgeon at Guy’s and St Thomas’s Hospital. He is also Vice-President of the European Laryngological Society and is the Audit and Governance Lead for the ENT-UK Head and Neck Society. Our editor,...

Global hearing rehabilitation – an SFORL/IFOS collaboration

1 September 2018 | | ENTA - Audiology - Adult, ENTA - Audiology - Paediatric
International collaboration is more important than ever, and we hear from Prof Bernard Fraysse about a collaboration that grew out of the very successful IFOS meeting in Paris in 2017. The IFOS meeting in Paris in June 2017 was obviously...

VACANCY: Consultant Otolaryngologist, Wellington, New Zealand

25 October 2023 | Recruitment & Personnel
Location: Wellington Regional Hospital, Kenepuru Hospital and Hutt Hospital

FDA Approved Lenire Expands Number of US Clinics

1 March 2024 | Company Profiles, Contracts & Distributors, Research & Development
Neuromod Devices, the medical technology company that developed tinnitus treatment device, Lenire, has partnered with an additional 24 new US clinics to address the significant demand for the FDA Approved tinnitus treatment device.

Controlled clinical trial results for FDA-approved tinnitus treatment device Lenire published in Nature Communications

12 September 2024 | Company Profiles, Research & Development
Nature Communications has published the peer-reviewed results of Neuromod Devices’ TENT-A3 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A3) clinical trial for the first and only FDA-approved bimodal tinnitus treatment device, Lenire.